Aktienanalyse wird geladen …
VTR · NYSE · Real Estate (REIT) · USA
86,84 $
| Geschäftsjahr | Umsatz | Nettogewinn | EPS (GAAP) | Aktien (verw., gesamt) | SBC in Stück | Bruttomarge | Nettomarge | FCF / Aktie | SBC / Aktie | Dividende / Aktie |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 5,83 Mrd. | 251,38 Mio. | 0,54 $ | 462,62 Mio. | 0,4 Mio · 0,1 % | 41,4 % | 4,3 % | -2,77 $ | 0,08 $ | 1,92 $ |
| 2024 | 4,92 Mrd. | 81,15 Mio. | 0,19 $ | 416,37 Mio. | 0,4 Mio · 0,1 % | 42,6 % | 1,7 % | -2,88 $ | 0,07 $ | 1,80 $ |
| 2023 | 4,5 Mrd. | -40,97 Mio. | -0,10 $ | 405,67 Mio. | 0,4 Mio · 0,1 % | 43,1 % | -0,9 % | 1,16 $ | 0,08 $ | 1,80 $ |
| 2022 | 4,13 Mrd. | -47,45 Mio. | -0,12 $ | 403,45 Mio. | 0,4 Mio · 0,1 % | 44,7 % | -1,2 % | 0,54 $ | 0,08 $ | 1,80 $ |
| 2021 | 3,83 Mrd. | 49,01 Mio. | 0,13 $ | 386,3 Mio. | 0,4 Mio · 0,1 % | 45,4 % | 1,3 % | -2,01 $ | 0,08 $ | 1,80 $ |
| 2020 | 3,8 Mrd. | 439,15 Mio. | 1,17 $ | 376,5 Mio. | 0,2 Mio · 0,1 % | 48,9 % | 11,6 % | 2,24 $ | 0,06 $ | 2,14 $ |
| Quartal | Umsatz | Nettogewinn | EPS | Aktien (verw., gesamt) | Nettomarge | FCF / Aktie |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,73 Mrd. | 70,57 Mio. | 0,14 $ | 497,72 Mio. | 4,1 % | — |
| Q1 2026 | 1,66 Mrd. | 55,91 Mio. | 0,11 $ | 486,72 Mio. | 3,4 % | — |
| Q4 2025 | 1,57 Mrd. | 70,2 Mio. | 0,15 $ | 480,76 Mio. | 4,5 % | — |
| Q3 2025 | 1,49 Mrd. | 66,05 Mio. | 0,14 $ | 463,42 Mio. | 4,4 % | — |
| Q2 2025 | 1,42 Mrd. | 68,26 Mio. | 0,15 $ | 459,09 Mio. | 4,8 % | — |
| Q1 2025 | 1,36 Mrd. | 46,87 Mio. | 0,10 $ | 446,42 Mio. | 3,5 % | — |
| Q4 2024 | 1,29 Mrd. | 56,84 Mio. | 0,12 $ | — | 4,4 % | -4,29 $ |
| Q3 2024 | 1,24 Mrd. | 19,24 Mio. | 0,05 $ | 419,47 Mio. | 1,6 % | — |
Despite Sale, Baron Capital Maintains Outlook on Ventas (VTR)
Evercore ISI Adjusts Price Target on Ventas to $100 From $101, Maintains Outperform Rating
Ventas (VTR) Stock May Trade At A Discount Following Its 124% Run
Why Ventas (VTR) is a Top Dividend Stock for Your Portfolio
Ventas Stock: Is VTR Outperforming the Real Estate Sector?
Ventas, Inc. is a healthcare real estate investment trust that owns and manages properties serving senior living, outpatient medical, research, and post-acute care markets. The company’s portfolio includes senior housing communities, medical office buildings, life science and research centers, hospitals, skilled nursing facilities, and other healthcare-related assets across North America and the United Kingdom. Ventas operates through three core segments: Senior Housing Operating Portfolio, Outpatient Medical and Research Portfolio, and Triple-net Leased Properties. Its business model focuses on acquiring, leasing, developing, and managing specialized real estate that supports healthcare providers, operators, and institutions. Ventas also maintains an institutional capital management platform that provides access to healthcare and longevity-focused real estate opportunities. Headquartered in Chicago, Illinois, Ventas plays a significant role in the healthcare property market by connecting real estate ownership with essential care delivery and research infrastructure.
WebsiteMit einem Konto testest du Glancefield Pro 3 Tage gratis und bewertest VTR und jede andere Aktie unbegrenzt.